SG27894G - Injectable compositions containing 25-cyclohexyl-avermectin B1 - Google Patents

Injectable compositions containing 25-cyclohexyl-avermectin B1

Info

Publication number
SG27894G
SG27894G SG27894A SG27894A SG27894G SG 27894 G SG27894 G SG 27894G SG 27894 A SG27894 A SG 27894A SG 27894 A SG27894 A SG 27894A SG 27894 G SG27894 G SG 27894G
Authority
SG
Singapore
Prior art keywords
avermectin
cyclohexyl
compositions containing
injectable compositions
injectable
Prior art date
Application number
SG27894A
Other languages
English (en)
Inventor
Stephen Richard Wicks
Edward Davison
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898908071A external-priority patent/GB8908071D0/en
Priority to ES90303716T priority Critical patent/ES2052173T3/es
Priority to DK90303716.6T priority patent/DK0393890T3/da
Priority to EP90303716A priority patent/EP0393890B1/de
Priority to APAP/P/1990/000174A priority patent/AP133A/en
Priority to AU53119/90A priority patent/AU609660B2/en
Priority to NO901637A priority patent/NO175882C/no
Priority to SU904743681A priority patent/RU1836084C/ru
Priority to FI901816A priority patent/FI92015C/fi
Priority to OA59772A priority patent/OA09203A/xx
Priority to CN90102072A priority patent/CN1035356C/zh
Priority to JP2096150A priority patent/JPH0647548B2/ja
Priority to EG22590A priority patent/EG18956A/xx
Priority to GR920402116T priority patent/GR3005794T3/el
Priority to SG27894A priority patent/SG27894G/en
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to HK39294A priority patent/HK39294A/xx
Publication of SG27894G publication Critical patent/SG27894G/en
Priority to CY177795A priority patent/CY1777A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
SG27894A 1989-04-11 1994-02-22 Injectable compositions containing 25-cyclohexyl-avermectin B1 SG27894G (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
ES90303716T ES2052173T3 (es) 1989-04-11 1990-04-06 Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.
DK90303716.6T DK0393890T3 (da) 1989-04-11 1990-04-06 Injicerbart præparat indeholdende 25-cyclohexyl-avermectin B1
EP90303716A EP0393890B1 (de) 1989-04-11 1990-04-06 Injizierbare Arzneizubereitungen, die 25-Cyclohexylavermectin B1 enthalten
APAP/P/1990/000174A AP133A (en) 1989-04-11 1990-04-09 Antiparasitical Formulations
FI901816A FI92015C (fi) 1989-04-11 1990-04-10 Menetelmä injektoitavan, loistenvastaisen koostumuksen valmistamiseksi
NO901637A NO175882C (no) 1989-04-11 1990-04-10 Fremgangsmåte ved fremstilling av parenterale, antiparasittiske formuleringer av forbindelsen 25-cykloheksyl-avermectin B1
SU904743681A RU1836084C (ru) 1989-04-11 1990-04-10 Способ получени препарата дл лечени паразитарных заболеваний животных
AU53119/90A AU609660B2 (en) 1989-04-11 1990-04-10 Antiparasitic formulations
OA59772A OA09203A (fr) 1989-04-11 1990-04-10 "Formulations antiparasitaires parentérales de 25-cyclohexyl-avermectine B1".
EG22590A EG18956A (en) 1989-04-11 1990-04-11 Antiparasitic formulations
JP2096150A JPH0647548B2 (ja) 1989-04-11 1990-04-11 抗寄生虫剤
CN90102072A CN1035356C (zh) 1989-04-11 1990-04-11 制备抗寄生虫制剂的方法
GR920402116T GR3005794T3 (de) 1989-04-11 1992-09-24
SG27894A SG27894G (en) 1989-04-11 1994-02-22 Injectable compositions containing 25-cyclohexyl-avermectin B1
HK39294A HK39294A (en) 1989-04-11 1994-04-28 Injectable compositions containing 25-cyclohexyl-avermectin B1
CY177795A CY1777A (en) 1989-04-11 1995-10-20 Injectable compositions containing 25-cyclohexyl-avermectin B1

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898908071A GB8908071D0 (en) 1989-04-11 1989-04-11 Antiparasitic formulations
SG27894A SG27894G (en) 1989-04-11 1994-02-22 Injectable compositions containing 25-cyclohexyl-avermectin B1

Publications (1)

Publication Number Publication Date
SG27894G true SG27894G (en) 1995-03-17

Family

ID=26295191

Family Applications (1)

Application Number Title Priority Date Filing Date
SG27894A SG27894G (en) 1989-04-11 1994-02-22 Injectable compositions containing 25-cyclohexyl-avermectin B1

Country Status (16)

Country Link
EP (1) EP0393890B1 (de)
JP (1) JPH0647548B2 (de)
CN (1) CN1035356C (de)
AP (1) AP133A (de)
AU (1) AU609660B2 (de)
CY (1) CY1777A (de)
DK (1) DK0393890T3 (de)
EG (1) EG18956A (de)
ES (1) ES2052173T3 (de)
FI (1) FI92015C (de)
GR (1) GR3005794T3 (de)
HK (1) HK39294A (de)
NO (1) NO175882C (de)
OA (1) OA09203A (de)
RU (1) RU1836084C (de)
SG (1) SG27894G (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
EP0928136B1 (de) * 1996-06-05 2003-10-22 Ashmont Holdings Limited Injizierbare zusammensetzungen
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
KR20000025762A (ko) * 1998-10-14 2000-05-06 유충식 이버멕틴류의 가용화 조성물
GB9827727D0 (en) 1998-12-16 1999-02-10 Pfizer Ltd Antiparasitic formulations
NZ590141A (en) * 2008-06-24 2012-05-25 Merial Ltd Anthelminthic formulations including castor oil and another vegetable oil
CA2750626C (en) * 2009-02-16 2013-10-01 Pfizer Inc. High dosage doramectin formulation
WO2011043962A2 (en) * 2009-10-07 2011-04-14 Wyeth Llc Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1182857B (it) * 1984-09-14 1987-10-05 Glaxo Group Ltd Composti antibiotici, composizioni antiparassitarie che li contengono e procedimento per prepararli ed applicarli
ES8802229A1 (es) * 1985-04-30 1988-04-16 Glaxo Group Ltd Un procedimiento para preparar nuevos derivados lactonicos macrociclicos.
US4707470A (en) * 1985-05-17 1987-11-17 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation
EP0285561A3 (de) * 1987-03-27 1989-10-25 Ciba-Geigy Ag Parasitizide und insektizide Milbemycin-Derivate
ATE87926T1 (de) * 1987-11-09 1993-04-15 Pfizer Ethylierte avermectine.

Also Published As

Publication number Publication date
FI92015C (fi) 1994-09-26
RU1836084C (ru) 1993-08-23
FI901816A0 (fi) 1990-04-10
CN1035356C (zh) 1997-07-09
FI92015B (fi) 1994-06-15
NO175882C (no) 1994-12-28
CY1777A (en) 1995-10-20
NO175882B (no) 1994-09-19
DK0393890T3 (da) 1992-09-28
EP0393890A1 (de) 1990-10-24
AU5311990A (en) 1990-11-08
AP9000174A0 (en) 1990-04-30
ES2052173T3 (es) 1994-07-01
JPH02290820A (ja) 1990-11-30
JPH0647548B2 (ja) 1994-06-22
AP133A (en) 1991-06-05
OA09203A (fr) 1992-06-30
GR3005794T3 (de) 1993-06-07
NO901637D0 (no) 1990-04-10
HK39294A (en) 1994-05-06
CN1046282A (zh) 1990-10-24
EG18956A (en) 1994-04-30
EP0393890B1 (de) 1992-08-12
NO901637L (no) 1990-10-12
AU609660B2 (en) 1991-05-02

Similar Documents

Publication Publication Date Title
AP9000216A0 (en) Injectable paraciticidal composition
GB8908361D0 (en) Composition
HK39294A (en) Injectable compositions containing 25-cyclohexyl-avermectin B1
GB8904862D0 (en) Compositions
HU900135D0 (en) New harbicid compositions
ZA908514B (en) Filme-forming compositions
EP0386359A3 (en) Konjak-containing composition
GB8927010D0 (en) Compositions
GB2231575B (en) Command-curable composition
GB8902894D0 (en) Compositions
GB8916151D0 (en) Composition
GB8909729D0 (en) Compositions
GB9009572D0 (en) Compositions
GB9012302D0 (en) Composition
EP0434164A3 (en) Frying-fat composition
GB8910472D0 (en) Compositions
GB8915752D0 (en) Compositions
GB8918863D0 (en) Compositions
GB8903989D0 (en) Compositions
GB8906824D0 (en) Compositions
GB8914614D0 (en) Compositions
GB8906336D0 (en) Compositions
GB8906337D0 (en) Compositions
GB8909943D0 (en) Compositions
GB8927240D0 (en) Compositions